Intellego Technologies AB

Equities

INT

SE0016075063

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm 11:29:51 2024-05-24 am EDT 5-day change 1st Jan Change
30.8 SEK +7.32% Intraday chart for Intellego Technologies AB +12.61% +82.25%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sweden's Intellego Technologies Names CFO MT
Intellego Technologies AB Appoints Petra Olofsson as Chief Financial Officer CI
Intellego Technologies AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Intellego Technologies AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Intellego Technologies Obtains Up to SEK40 Million Credit Line Ahead of New Product Launches MT
Intellego Technologies AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Intellego Technologies AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Intellego Technologies AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Intellego Technologies AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 CI
Certain Shares of Intellego Technologies AB are subject to a Lock-Up Agreement Ending on 24-DEC-2022. CI
Intellego Technologies AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Intellego Technologies AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Intellego Technologies AB (OM:INT) agreed to acquire Daro Group Limited for ú10 million. CI
Intellego Technologies AB Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Intellego Technologies AB (OM:INT) signed letter of intent to acquire majority stake in Jiangyin Feiyang Instrument Co., Ltd CI
Intellego Technologies AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021 CI
Intellego Technologies AB Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Certain Shares of Intellego Technologies AB are subject to a Lock-Up Agreement Ending on 24-DEC-2021. CI
Intellego Technologies AB has completed an IPO in the amount of SEK 14.999998 million. CI
Intellego Technologies AB has filed an IPO in the amount of SEK 14.999998 million. CI
Chart Intellego Technologies AB
More charts
Intellego Technologies AB is a Sweden-based company engaged in photochromatic indicator technology. The Company is a manufacturer of colorimetric ultraviolet indicators. UVC Dosimeters are used in Healthcare, Hospitality, Retail, Transportation and Commercial Applications around the world. With its patented photochromic ink that changes color based on exposure to ultraviolet irradiation or specific substances, Intellego produces dosimeters in a variety of formats and custom options to meet the constantly evolving needs of Ultraviolet Device Manufacturers (OEMs) and end-users. Intellego Technologies is headquartered in Stockholm, with product development and manufacturing based in the southwest region of Sweden.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. INT Stock
  4. News Intellego Technologies AB
  5. Sweden's Intellego Technologies Names CFO